Barclays’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $334K | Sell |
12,052
-43,291
| -78% | -$1.2M | ﹤0.01% | 3253 |
|
|
2025
Q1 | $1.23M | Sell |
55,343
-16,553
| -23% | -$368K | ﹤0.01% | 2332 |
|
|
2024
Q4 | $1.42M | Buy |
71,896
+7,267
| +11% | +$144K | ﹤0.01% | 2423 |
|
|
2024
Q3 | $1.62M | Buy |
64,629
+29,790
| +86% | +$744K | ﹤0.01% | 2333 |
|
|
2024
Q2 | $650K | Sell |
34,839
-7,308
| -17% | -$136K | ﹤0.01% | 2373 |
|
|
2024
Q1 | $831K | Sell |
42,147
-143,609
| -77% | -$2.83M | ﹤0.01% | 2536 |
|
|
2023
Q4 | $3.26M | Buy |
185,756
+10,231
| +6% | +$179K | ﹤0.01% | 1814 |
|
|
2023
Q3 | $3.05M | Buy |
175,525
+12,867
| +8% | +$223K | ﹤0.01% | 1430 |
|
|
2023
Q2 | $2.29M | Buy |
162,658
+479
| +0.3% | +$6.75K | ﹤0.01% | 1660 |
|
|
2023
Q1 | $1.75M | Buy |
162,179
+102,172
| +170% | +$1.1M | ﹤0.01% | 1735 |
|
|
2022
Q4 | $899K | Buy |
60,007
+37,666
| +169% | +$564K | ﹤0.01% | 2211 |
|
|
2022
Q3 | $287K | Buy |
22,341
+5,969
| +36% | +$76.7K | ﹤0.01% | 2887 |
|
|
2022
Q2 | $158K | Sell |
16,372
-3,289
| -17% | -$31.7K | ﹤0.01% | 3260 |
|
|
2022
Q1 | $195K | Sell |
19,661
-35,873
| -65% | -$356K | ﹤0.01% | 3331 |
|
|
2021
Q4 | $653K | Sell |
55,534
-21,026
| -27% | -$247K | ﹤0.01% | 2408 |
|
|
2021
Q3 | $872K | Buy |
76,560
+56,731
| +286% | +$646K | ﹤0.01% | 2323 |
|
|
2021
Q2 | $275K | Sell |
19,829
-235,707
| -92% | -$3.27M | ﹤0.01% | 2765 |
|
|
2021
Q1 | $4.73M | Sell |
255,536
-425,364
| -62% | -$7.87M | ﹤0.01% | 1232 |
|
|
2020
Q4 | $12M | Buy |
680,900
+392,512
| +136% | +$6.94M | 0.01% | 731 |
|
|
2020
Q3 | $4.42M | Buy |
288,388
+271,796
| +1,638% | +$4.16M | ﹤0.01% | 1032 |
|
|
2020
Q2 | $423K | Buy |
16,592
+10,367
| +167% | +$264K | ﹤0.01% | 2416 |
|
|
2020
Q1 | $97K | Sell |
6,225
-12,058
| -66% | -$188K | ﹤0.01% | 2844 |
|
|
2019
Q4 | $202K | Buy |
18,283
+6,864
| +60% | +$75.8K | ﹤0.01% | 3167 |
|
|
2019
Q3 | $98K | Buy |
11,419
+264
| +2% | +$2.27K | ﹤0.01% | 3411 |
|
|
2019
Q2 | $151K | Buy |
11,155
+6,790
| +156% | +$91.9K | ﹤0.01% | 3360 |
|
|
2019
Q1 | $80K | Buy |
4,365
+1,311
| +43% | +$24K | ﹤0.01% | 3440 |
|
|
2018
Q4 | $86K | Buy |
3,054
+624
| +26% | +$17.6K | ﹤0.01% | 3021 |
|
|
2018
Q3 | $62K | Buy |
+2,430
| New | +$62K | ﹤0.01% | 3653 |
|